Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05142696
Title A Safety Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) Patients in Combination With Carboplatin, Etoposide and Tislelizumab
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Georgetown University Lombardi Cancer Center RECRUITING Washington District of Columbia 20007 2197 United States Details
University of Kentucky RECRUITING Lexington Kentucky 40536 United States Details
University Hospitals Of Cleveland RECRUITING Cleveland Ohio 44106 United States Details
Novartis Investigative Site RECRUITING Lille 59000 France Details
Novartis Investigative Site RECRUITING Marseille Cedex 05 13885 France Details
Novartis Investigative Site RECRUITING Montpellier 34298 France Details
Novartis Investigative Site RECRUITING Villejuif 94800 France Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Koeln 50937 Germany Details
Novartis Investigative Site RECRUITING Malaga Andalucia 29010 Spain Details
Novartis Investigative Site RECRUITING Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site RECRUITING Madrid 28009 Spain Details
Novartis Investigative Site RECRUITING Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field